Pfizer has pursued deals of all sizes to build new revenue streams, but the outlook underscores that those investments are still some distance from paying off.
Source: CNBC
Wednesday, 17. December 2025
Share:
16. December 2025 16:12
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
